Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade

por Reynolds, Kerry, Thomas, Molly, Dougan, Michael
Publicado 2018

Precision medicine and personalized breast cancer: combination pertuzumab therapy

por Reynolds, Kerry, Sarangi, Sasmit, Bardia, Aditya, Dizon, Don S
Publicado 2014

Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the US

por Watson, Tina R., Gao, Xin, Reynolds, Kerry L., Kong, Chung Yin
Publicado 2020

A review of neurotoxicities associated with immunotherapy and a framework for evaluation

por Burton, Leeann B, Eskian, Mahsa, Guidon, Amanda C, Reynolds, Kerry L
Publicado 2021

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer

por Zhang, Lili, Reynolds, Kerry L., Lyon, Alexander R., Palaskas, Nicolas, Neilan, Tomas G.
Publicado 2021

Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy

por Falade, Ayo S., Reynolds, Kerry L., Zubiri, Leyre, Deshpande, Vikram, Fintelmann, Florian J., Dougan, Michael, Mooradian, Meghan J.
Publicado 2022

Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States

por Criss, Steven D., Mooradian, Meghan J., Watson, Tina R., Gainor, Justin F., Reynolds, Kerry L., Kong, Chung Yin
Publicado 2019

Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis

por Qualls, David, Seethapathy, Harish, Bates, Halla, Tajmir, Shahein, Heidari, Pedram, Endres, Paul, Reynolds, Kerry, Lawrence, Donald, Sise, Meghan
Publicado 2019

COVID-19 and immune checkpoint inhibitors: initial considerations

por Sullivan, Ryan J, Johnson, Douglas B, Rini, Brian I, Neilan, Tomas G, Lovly, Christine M, Moslehi, Javid J, Reynolds, Kerry L
Publicado 2020

Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control

por Hughes, Michael S., Zheng, Hui, Zubiri, Leyre, Molina, Gabriel E., Chen, Steven T., Mooradian, Meghan J., Allen, Ian M., Reynolds, Kerry L., Dougan, Michael
Publicado 2019

Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis

por Durbin, Sienna M, Mooradian, Meghan J, Fintelmann, Florian Johannes, Zubiri, Leyre, Chute, Donald F, Kambadakone, Avinash, Pisuchpen, Nisanard, Reynolds, Kerry L, Dougan, Michael
Publicado 2020

Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study

por Lee, Meghan D, Seethapathy, Harish, Strohbehn, Ian A, Zhao, Sophia H, Boland, Genevieve M, Fadden, Riley, Sullivan, Ryan, Reynolds, Kerry L, Sise, Meghan E
Publicado 2021

Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors

por Klebanov, Nikolai, Pahalyants, Vartan, Murphy, William S., Theodosakis, Nicholas, Zubiri, Leyre, Klevens, R. Monina, Kwatra, Shawn G., Lilly, Evelyn, Reynolds, Kerry L., Semenov, Yevgeniy R.
Publicado 2021

Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study

por Tiu, Bruce C, Strohbehn, Ian A, Zhao, Sophia, Ouyang, Tianqi, Hanna, Paul, Wang, Qiyu, Gupta, Shruti, Leaf, David E, Reynolds, Kerry L, Sise, Meghan E
Publicado 2023

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma

por Seethapathy, Harish, Bates, Halla, Chute, Donald F., Strohbehn, Ian, Strohbehn, Samuel, Fadden, Riley M., Reynolds, Kerry L., Cohen, Justine V., Sullivan, Ryan J., Sise, Meghan E.
Publicado 2020

Evaluation of a protocol for eliciting narrative accounts of pediatric inpatient experiences of care

por Martino, Steven C., Reynolds, Kerry A., Grob, Rachel, Palimaru, Alina I., Zelazny, Sarah, Slaughter, Mary E., Rybowski, Lise, Parker, Andrew M., Toomey, Sara L., Schuster, Mark A., Schlesinger, Mark
Publicado 2023

Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR

por Hanna, Paul E., Wang, Qiyu, Strohbehn, Ian, Moreno, Daiana, Harden, Destiny, Ouyang, Tianqi, Katz-Agranov, Nurit, Seethapathy, Harish, Reynolds, Kerry L., Gupta, Shruti, Leaf, David E., Sise, Meghan E.
Publicado 2023

Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer

por Hanna, Paul E., Wang, Qiyu, Strohbehn, Ian A., Moreno, Daiana, Harden, Destiny, Ouyang, Tianqi, Katz-Agranov, Nurit, Seethapathy, Harish, Reynolds, Kerry L., Gupta, Shruti, Leaf, David E., Sise, Meghan E.
Publicado 2023

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database f...

por Kalinich, Mark, Murphy, William, Wongvibulsin, Shannon, Pahalyants, Vartan, Yu, Kun-Hsing, Lu, Chenyue, Wang, Feicheng, Zubiri, Leyre, Naranbhai, Vivek, Gusev, Alexander, Kwatra, Shawn G, Reynolds, Kerry L, Semenov, Yevgeniy R
Publicado 2021

Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma

por Wang, Qiyu, Strohbehn, Ian A., Zhao, Sophia, Seethapathy, Harish, Strohbehn, Samuel D., Hanna, Paul, Lee, Meghan, Fadden, Riley, Sullivan, Ryan J., Boland, Genevieve M., Reynolds, Kerry L., Sise, Meghan E.
Publicado 2022